Journal
FUTURE ONCOLOGY
Volume 10, Issue 16, Pages 2687-2697Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon.14.199
Keywords
biomarker; cancer; CRKL; invasion; metastasis
Categories
Funding
- National Natural Science Foundation of China [81050010, 81171957, 81272186, 81100722]
- Outstanding Youth Scholar Growth Project in University and College of Liaoning [LJQ2011094]
- Liaoning BaiQianWan Talent Project [2012921015]
Ask authors/readers for more resources
V-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) is a member of CRK family. It acts as an adaptor protein in intracellular signal transduction. CRKL has been reported overexpressed in a variety of cancers affecting the aggressive and malignant behaviors of cancer cells. CRKL seems to show a tumor-promotion role in gastric cancer, glioblastoma multiforme, hepatocellular carcinoma, bladder cancer, lung cancer, colon cancer, ovarian cancer, leukemia, breast cancer, head and neck cancer, rhabdomyosarcoma and neuroblastoma. The association of CRKL with malignant tumors and its potential action mechanisms were summarized. CRKL has the potential to be used as a biomarker for the diagnosis, treatment and prognosis of certain tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available